Canopy Growth (CGC) stock forecast for 2022
Last update: December 4, 2022 (11:30)Sector: Healthcare
The share price of Canopy Growth Corp. (CGC) now
What analysts predict: $5.26
52-week high/low: $11.2 / $2.13
50/200 Day Moving Average: $3.159 / $4.389
This figure corresponds to the average price over the previous 50/200 days. For Canopy Growth stocks, the 50-day moving average is the support level today.
For Canopy Growth stocks, the 200-day moving average is the resistance level today.
Are you interested in Canopy Growth stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Canopy Growth stock price in 2022. How much will one Canopy Growth share be worth in 2022?
Is it worth taking profit / loss on Canopy Growth stock now or waiting? What are analysts' forecasts for Canopy Growth stock?
We forecast Canopy Growth stock performance using neural networks based on historical data on Canopy Growth stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Canopy Growth stock prediction results are shown below and presented as a graph, table and text information.
Canopy Growth stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Canopy Growth analysts is $5.26.
Today 200 Day Moving Average is the resistance level (4.389 $).
50 Day Moving Average is the support level (3.159 $).
Historical and forecast chart of Canopy Growth stock
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Canopy Growth stock price can be found in the table below.
Canopy Growth (CGC) Forecast for 2022
Canopy Growth information and performance
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers. The company’s products include dried cannabis flowers, oils and concentrates, and soft capsules. It offers its products under Tweed, Quatreau, Deep Space, Healing Spectrum, First and Free, Taiwan Dollar, It Works, BioSteel, CraftGrow DNA Genetics, Tokyo Smoke, Changed, Delicious Parcels, Van der Pop, and Beans and Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and the NHL Alumni Association to study the efficacy of CBD-based therapy in alleviating persistent post-exposure symptoms. As of February 14, 2020, she operated 28 cannabis retail stores called Tweed or Tokyo Smoke. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smits Falls, Canada.
Canopy Growth Address
1 HERSHEY DRIVE, SMITH FALLS, ON, CA
Market Capitalization: 2 468 625 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -410 145 984 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.103
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.014
Enterprise Value (EV) /Revenue
EV To EBITDA: -0.69
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 485933000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Canopy Growth price target for 2022 by month
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.